Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;39(2):e25144.
doi: 10.1002/jcla.25144. Epub 2024 Dec 27.

Construction of Candida albicans pRB895-SAP2-SC5314 With SAP2 High Expression and Its Effects on Adhesion

Affiliations

Construction of Candida albicans pRB895-SAP2-SC5314 With SAP2 High Expression and Its Effects on Adhesion

Lan Xue et al. J Clin Lab Anal. 2025 Jan.

Abstract

Background: SAP2 is closely associated with the pathogenicity and drug resistance of Candida albicans (C. albicans). Our study aimed to construct C. albicans with SAP2 overexpression (pRB895-SAP2-SC5314) to explore the influence of SAP2 on the adhesion of C. albicans and predict the interaction between magnolol and Sap2 by molecular docking.

Methods: The recombinant plasmid pRB895-SAP2 with high SAP2 expression was prepared using a plasmid extraction kit and transformed into C. albicans strain SC5314 using an improved lithium acetate conversion method to construct PRB895-SAP2-SC5314. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to detect the expression of adhesion-related genes in the different strains. Molecular docking and visual analysis of magnolol and Sap2 were performed using the CB-DOCK2 platform.

Results: Compared with the control SC5341 and SC5341 transfected with pRB895, SAP2 expression was significantly higher in the pRB895-SAP2-SC5314 strain (p < 0.05). Based on the sequencing and mapping results, the pRB895-SAP2-SC5314 strain was successfully prepared. SAP2 overexpression significantly downregulated ALS1 expression (p < 0.05), whereas ALS3, TEC1, HOG1, PHR1, and TUP1 expression was downregulated in C. albicans (p < 0.05). The optimal docking result for magnolol and Sap2 protein was -8.1 kcal/mol of vina score, which was considered good docking.

Conclusions: SAP2 overexpression may strengthen the adhesion and pathogenicity of C. albicans, and magnolol may act as an Sap2 inhibitor that affects the adhesion of C. albicans.

Keywords: C. albicans; SAP2; SAP2adhesion; magnolol; pRB895‐SAP2‐SC5314 strain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Identification of plasmids pRB895 and pRB895‐SAP2, as well as strains pRB895‐SC5314 and pRB895‐SAP2‐SC5314. Gel electrophoresis and mapping results of pRB895‐SAP2 plasmids (A) and empty plasmid pRB895 (B). Sequencing and comparison of pRB895‐SC5314 (C) and pRB895‐SAP2‐SC5314 (D).
FIGURE 2
FIGURE 2
Validation of all primers. Gel electrophoresis results of HOG1, TUP1, SAP2, PHR1, TEC1, ALS3, ALS1, and ACT1 in the strains pRB895‐SAP2‐SC5314 (A), pRB895‐SC5314 (B), and the control strain SC5314 (C). Lanes 4, 5, 6, 7, 8, 9, 10, and 11 represent the primers HOG1, TUP1, SAP2, PHR1, TEC1, ALS3, ALS1 and ACT1, respectively, and lane 12 represents the marker (100–2000 kD).
FIGURE 3
FIGURE 3
Expression of SAP2 in SC5314, pRB895‐SC5314, and pRB895‐SAP2‐SC5314 strains measured using qRT‐PCR. *p < 0.05 versus SC5314; # p < 0.05 versus pRB895‐SC5314.
FIGURE 4
FIGURE 4
Effects of SAP2 on the expression of adhesion‐related genes. The expression levels of ALS1, ALS3, HOG1, PHR1, TEC1, and TUP1 in the different strains were determined using qRT‐PCR. *p < 0.05 versus SC5314; # p < 0.05 versus pRB895‐SC5314.
FIGURE 5
FIGURE 5
Interaction between magnolol and Sap2 proteins by molecular docking. (A) After 20 molecular docking cycles, the binding energies showed good results. (B) The structure visualization of the optimal coupling results (−8.1 kcal/mol of vina score).

Similar articles

References

    1. Soriano A., Honore P. M., Puerta‐Alcalde P., et al., “Invasive Candidiasis: Current Clinical Challenges and Unmet Needs in Adult Populations,” Journal of Antimicrobial Chemotherapy 78, no. 7 (2023): 1569–1585, 10.1093/jac/dkad139. - DOI - PMC - PubMed
    1. Volkova M., Atamas A., Tsarenko A., Rogachev A., and Guskov A., “Cation Transporters of Candida albicans ‐New Targets to Fight Candidiasis?,” Biomolecules 11, no. 4 (2021): 584, 10.3390/biom11040584. - DOI - PMC - PubMed
    1. Wake R. M., Allebone‐Salt P. E., John L. L. H., et al., “Optimizing the Treatment of Invasive Candidiasis‐A Case for Combination Therapy,” Open Forum Infectious Diseases 11, no. 6 (2024): ofae072, 10.1093/ofid/ofae072. - DOI - PMC - PubMed
    1. Coste A. T., Kritikos A., Li J., et al., “Emerging Echinocandin‐Resistant Candida Albicans and Glabrata in Switzerland,” Infection 48, no. 5 (2020): 761–766, 10.1007/s15010-020-01475-8. - DOI - PMC - PubMed
    1. Mogavero S. and Hube B., “ Candida albicans Interaction with Oral Epithelial Cells: Adhesion, Invasion, and Damage Assays,” Methods in Molecular Biology 2260 (2021): 133–143, 10.1007/978-1-0716-1182-1_9. - DOI - PubMed

MeSH terms

LinkOut - more resources